<p>随着美国市场连续第四个交易日上涨，受益于超出预期的 GDP 增长和科技行业的反弹，市场的关注点转向那些能够在这些动态条件下应对的高增长科技股。在这种环境中，识别有前景的股票需要评估它们在应对经济变化和技术进步方面的创新潜力和适应能力。</p>
<h3>美国十大高增长科技公司</h3>
<table>
<thead>
<tr>
<th>名称</th>
<th>收入增长</th>
<th>盈利增长</th>
<th>增长评级</th>
</tr>
</thead>
<tbody>
<tr>
<td>Marker Therapeutics</td>
<td>75.24%</td>
<td>59.07%</td>
<td>★★★★★★</td>
</tr>
<tr>
<td>Sanmina</td>
<td>31.01%</td>
<td>33.24%</td>
<td>★★★★★☆</td>
</tr>
<tr>
<td>Palantir Technologies</td>
<td>28.00%</td>
<td>32.57%</td>
<td>★★★★★★</td>
</tr>
<tr>
<td>Workday</td>
<td>11.13%</td>
<td>32.18%</td>
<td>★★★★★☆</td>
</tr>
<tr>
<td>Circle Internet Group</td>
<td>23.08%</td>
<td>84.58%</td>
<td>★★★★★☆</td>
</tr>
<tr>
<td>RenovoRx</td>
<td>71.45%</td>
<td>71.45%</td>
<td>★★★★★☆</td>
</tr>
<tr>
<td>Cellebrite DI</td>
<td>15.29%</td>
<td>20.24%</td>
<td>★★★★★☆</td>
</tr>
<tr>
<td>Zscaler</td>
<td>15.85%</td>
<td>45.93%</td>
<td>★★★★★☆</td>
</tr>
<tr>
<td>Procore Technologies</td>
<td>11.70%</td>
<td>116.48%</td>
<td>★★★★★☆</td>
</tr>
<tr>
<td>Duos Technologies Group</td>
<td>53.36%</td>
<td>152.11%</td>
<td>★★★★★☆</td>
</tr>
</tbody>
</table>
<p>点击这里查看我们美国高增长科技和人工智能股票筛选器中的 75 只股票的完整列表。</p>
<p>让我们从我们的专业筛选器中发现一些潜在的投资机会。</p>
<h2>ADMA Biologics (ADMA)</h2>
<p><strong>Simply Wall St 增长评级：</strong> ★★★★☆☆</p>
<p><strong>概述：</strong> ADMA Biologics, Inc. 是一家生物制药公司，专注于开发、生产和营销用于治疗免疫缺陷和传染病的特殊血浆衍生生物制剂，市值为 46.6 亿美元。</p>
<p><strong>运营：</strong> ADMA Biologics 主要通过其生物制造部门产生收入，该部门的收入为 4.8164 亿美元，而其血浆采集中心贡献了 677 万美元。</p>
<p>ADMA Biologics 展现出强劲的财务表现，过去一年盈利增长显著，达到 207.4%，远超行业增长。这一趋势得到了 23% 的年盈利增长预测和 19.6% 的年收入增长的支持，均超过市场平均水平。公司的战略研发投资至关重要，与其收入相结合，促进了创新并保持了在生物科技领域的竞争优势。最近，ADMA 提高了 2025 年和 2026 年的财务预测，同时通过今年 2301 万美元的积极股票回购继续提升股东价值。这些举措反映了在动态市场条件下扩大运营和潜在确保长期增长的积极态度。</p>
<ul>
<li>解锁我们对 ADMA Biologics 股票分析的全面见解，请查看本健康报告。</li>
<li>通过访问我们的历史表现报告，评估 ADMA Biologics 的历史表现。</li>
</ul>
<p><img src="https://imageproxy.pbkrs.com/https://images.simplywall.st/company/f89ca4c1-8d8c-472e-b71e-3bd45378af08/chart/revenue-and-expenses-breakdown?x-oss-process=image/auto-orient,1/interlace,1/resize,w_1440,h_1440/quality,q_95/format,jpg" alt="" original-src="https://imageproxy.pbkrs.com/https://images.simplywall.st/company/f89ca4c1-8d8c-472e-b71e-3bd45378af08/chart/revenue-and-expenses-breakdown"/></p>
<p>截至 2025 年 12 月的 ADMA 收入和支出明细</p>
<h2>CarGurus (CARG)</h2>
<p><strong>Simply Wall St 增长评级：</strong> ★★★★☆☆</p>
<p><strong>概述：</strong> CarGurus, Inc. 运营一个在线汽车平台，促进美国及国际范围内的车辆买卖，市值约为 36.9 亿美元。</p>
<p><strong>运营：</strong> 该公司主要通过其美国市场部门产生收入，该部门的收入为 8.0172 亿美元，数字批发部门的收入为 5035 万美元。</p>
<p>CarGurus 展现出显著的扭转局面，今年实现盈利，净收入为 1.0611 亿美元，而去年则出现净亏损。这一转变得益于 22.4% 的年盈利增长，超过美国市场平均水平的 16.2%。公司在研发和产品创新方面的战略重点体现在其最近推出的 PriceVantage，这是一种利用实时数据优化经销商定价策略的定价解决方案。该工具已经使参与的经销商在周转时间上显著超越竞争对手。此外，CarGurus 今年的股票回购总额达到 2.9523 亿美元，反映了其对股东价值的承诺和对持续增长的信心，尽管其收入预测的增长速度（每年 6.3%）低于市场（10.7%）。</p>
<ul>
<li>在我们的健康报告中更深入地了解 CarGurus 的潜力。</li>
<li>查看 CarGurus 的历史表现报告，以了解其过去的表现。</li>
</ul>
<p><img src="https://imageproxy.pbkrs.com/https://images.simplywall.st/company/de4c7c87-7486-4613-8996-bf1d7d679595/chart/revenue-and-expenses-breakdown?x-oss-process=image/auto-orient,1/interlace,1/resize,w_1440,h_1440/quality,q_95/format,jpg" alt="" original-src="https://imageproxy.pbkrs.com/https://images.simplywall.st/company/de4c7c87-7486-4613-8996-bf1d7d679595/chart/revenue-and-expenses-breakdown"/></p>
<p>截至 2025 年 12 月的 CARG 收入和支出明细</p>
<h2>Roku (ROKU)</h2>
<p><strong>Simply Wall St 增长评级：</strong> ★★★★☆☆</p>
<p><strong>概述：</strong> Roku, Inc. 运营一个电视流媒体平台，覆盖美国及国际市场，市值约为 160.8 亿美元。</p>
<p><strong>运营：</strong> Roku 主要通过其平台部门产生收入，该部门的收入为 39.6 亿美元，远超其设备部门的 5.8713 亿美元。</p>
<p>Roku 在竞争激烈的流媒体行业中的发展轨迹以战略创新和合作伙伴关系为标志，旨在增强其市场地位并应对行业挑战。最近，Roku 报告了显著的扭转，第三季度销售额达到 12.1 亿美元，较去年同期的 10.6 亿美元增长，反映出 11% 的年收入增长，超过美国市场平均水平的 10.7%。这一增长伴随着盈利能力的转变，净收入达到 2481 万美元，而去年同期则出现亏损。此外，Roku 与 DoubleVerify 的合作在打击连接电视广告中的广告欺诈方面发挥了关键作用，展示了其在平台上确保和提升广告质量的承诺。这些努力通过最近的财报结果和战略联盟得到了强调，不仅增强了 Roku 的收入来源，还巩固了其在数字广告领域的地位，为未来的增长奠定了坚实的基础。</p>
<ul>
<li>在这里深入了解 Roku 的具体情况，查看我们的详细健康报告。</li>
<li>通过我们的历史业绩报告评估 Roku 的过去表现。</li>
</ul>
<p><img src="https://imageproxy.pbkrs.com/https://images.simplywall.st/company/744f6447-c3ab-4606-b8bc-5bdfa4635280/chart/revenue-and-expenses-breakdown?x-oss-process=image/auto-orient,1/interlace,1/resize,w_1440,h_1440/quality,q_95/format,jpg" alt="" original-src="https://imageproxy.pbkrs.com/https://images.simplywall.st/company/744f6447-c3ab-4606-b8bc-5bdfa4635280/chart/revenue-and-expenses-breakdown"/></p>
<p>截至 2025 年 12 月的 ROKU 收入和支出细分</p>
<h2>总结</h2>
<ul>
<li>点击这里访问我们完整的 75 只美国高增长科技和人工智能股票索引。</li>
<li>投资了这些股票吗？通过 Simply Wall St 简化您的投资组合管理，并及时获取股票的关键更新提醒。</li>
<li>Simply Wall St 是您解锁全球市场趋势的关键，是一款面向前瞻性投资者的免费用户友好应用。</li>
</ul>
<h2>准备探索其他投资风格吗？</h2>
<ul>
<li>探索尚未获得显著分析师关注的高表现小型公司。</li>
<li>用显示强劲增长潜力的公司充实您的投资组合，得到分析师和管理层的乐观展望支持。</li>
<li>寻找现金流潜力良好但交易价格低于其公允价值的公司。</li>
</ul>
<p><em>本文由 Simply Wall St 撰写，内容具有一般性。<strong>我们基于历史数据和分析师预测提供评论，仅使用无偏见的方法，我们的文章不构成财务建议。</strong> 它不构成买入或卖出任何股票的推荐，也未考虑您的目标或财务状况。我们的目标是为您提供以基本数据驱动的长期分析。请注意，我们的分析可能未考虑最新的价格敏感公司公告或定性材料。Simply Wall St 在提到的任何股票中没有持仓。</em></p>
<p>用于国防和灾难的移动基础设施</p>
<p>下一波机器人技术不是人形的。它是完全自主的塔，在 30 分钟内提供 5G、ISR 和雷达，随处可达。</p>
<p>在下一轮合同之前获取投资者简报</p>
<p>代表 CiTech 赞助</p>

新美亚电子

ADMA生物制药

MRKR

PLTR

<p>美国市场因强劲的 GDP 增长和科技行业的反弹而出现上涨。投资者正关注高增长的科技股，评估它们的创新能力和适应性。顶尖公司包括 Marker Therapeutics、Sanmina 和 Palantir Technologies 等。ADMA Biologics、CarGurus 和 Roku 因其财务表现和战略举措而受到关注。ADMA 显示出强劲的盈利增长，CarGurus 已实现盈利，而 Roku 则通过战略合作伙伴关系提升其市场地位</p>

<p>As the United States market experiences a fourth consecutive session of gains, buoyed by better-than-expected GDP growth and a tech sector rally, attention turns to high-growth tech stocks that are poised to navigate these dynamic conditions. In this environment, identifying promising stocks involves assessing their potential for innovation and adaptability in response to economic shifts and technological advancements.</p>
<div class="lb-trans"><p>随着美国市场连续第四个交易日上涨，受益于超出预期的 GDP 增长和科技行业的反弹，市场的关注点转向那些能够在这些动态条件下应对的高增长科技股。在这种环境中，识别有前景的股票需要评估它们在应对经济变化和技术进步方面的创新潜力和适应能力。</p>
</div><h3>Top 10 High Growth Tech Companies In The United States</h3>
<div class="lb-trans"><h3>美国十大高增长科技公司</h3>
</div><table>
<thead>
<tr>
<th>Name</th>
<th>Revenue Growth</th>
<th>Earnings Growth</th>
<th>Growth Rating</th>
</tr>
</thead>
<tbody>
<tr>
<td>Marker Therapeutics</td>
<td>75.24%</td>
<td>59.07%</td>
<td>★★★★★★</td>
</tr>
<tr>
<td>Sanmina</td>
<td>31.01%</td>
<td>33.24%</td>
<td>★★★★★☆</td>
</tr>
<tr>
<td>Palantir Technologies</td>
<td>28.00%</td>
<td>32.57%</td>
<td>★★★★★★</td>
</tr>
<tr>
<td>Workday</td>
<td>11.13%</td>
<td>32.18%</td>
<td>★★★★★☆</td>
</tr>
<tr>
<td>Circle Internet Group</td>
<td>23.08%</td>
<td>84.58%</td>
<td>★★★★★☆</td>
</tr>
<tr>
<td>RenovoRx</td>
<td>71.45%</td>
<td>71.45%</td>
<td>★★★★★☆</td>
</tr>
<tr>
<td>Cellebrite DI</td>
<td>15.29%</td>
<td>20.24%</td>
<td>★★★★★☆</td>
</tr>
<tr>
<td>Zscaler</td>
<td>15.85%</td>
<td>45.93%</td>
<td>★★★★★☆</td>
</tr>
<tr>
<td>Procore Technologies</td>
<td>11.70%</td>
<td>116.48%</td>
<td>★★★★★☆</td>
</tr>
<tr>
<td>Duos Technologies Group</td>
<td>53.36%</td>
<td>152.11%</td>
<td>★★★★★☆</td>
</tr>
</tbody>
</table>
<div class="lb-trans"><table>
<thead>
<tr>
<th>名称</th>
<th>收入增长</th>
<th>盈利增长</th>
<th>增长评级</th>
</tr>
</thead>
<tbody>
<tr>
<td>Marker Therapeutics</td>
<td>75.24%</td>
<td>59.07%</td>
<td>★★★★★★</td>
</tr>
<tr>
<td>Sanmina</td>
<td>31.01%</td>
<td>33.24%</td>
<td>★★★★★☆</td>
</tr>
<tr>
<td>Palantir Technologies</td>
<td>28.00%</td>
<td>32.57%</td>
<td>★★★★★★</td>
</tr>
<tr>
<td>Workday</td>
<td>11.13%</td>
<td>32.18%</td>
<td>★★★★★☆</td>
</tr>
<tr>
<td>Circle Internet Group</td>
<td>23.08%</td>
<td>84.58%</td>
<td>★★★★★☆</td>
</tr>
<tr>
<td>RenovoRx</td>
<td>71.45%</td>
<td>71.45%</td>
<td>★★★★★☆</td>
</tr>
<tr>
<td>Cellebrite DI</td>
<td>15.29%</td>
<td>20.24%</td>
<td>★★★★★☆</td>
</tr>
<tr>
<td>Zscaler</td>
<td>15.85%</td>
<td>45.93%</td>
<td>★★★★★☆</td>
</tr>
<tr>
<td>Procore Technologies</td>
<td>11.70%</td>
<td>116.48%</td>
<td>★★★★★☆</td>
</tr>
<tr>
<td>Duos Technologies Group</td>
<td>53.36%</td>
<td>152.11%</td>
<td>★★★★★☆</td>
</tr>
</tbody>
</table>
</div><p>Click here to see the full list of 75 stocks from our US High Growth Tech and AI Stocks screener.</p>
<div class="lb-trans"><p>点击这里查看我们美国高增长科技和人工智能股票筛选器中的 75 只股票的完整列表。</p>
</div><p>Let's uncover some gems from our specialized screener.</p>
<div class="lb-trans"><p>让我们从我们的专业筛选器中发现一些潜在的投资机会。</p>
</div><h2>ADMA Biologics (ADMA)</h2>
<div class="lb-trans"><h2>ADMA Biologics (ADMA)</h2>
</div><p><strong>Simply Wall St Growth Rating:</strong> ★★★★☆☆</p>
<div class="lb-trans"><p><strong>Simply Wall St 增长评级：</strong> ★★★★☆☆</p>
</div><p><strong>Overview:</strong> ADMA Biologics, Inc. is a biopharmaceutical company that focuses on developing, manufacturing, and marketing specialty plasma-derived biologics for treating immune deficiencies and infectious diseases globally, with a market cap of $4.66 billion.</p>
<div class="lb-trans"><p><strong>概述：</strong> ADMA Biologics, Inc. 是一家生物制药公司，专注于开发、生产和营销用于治疗免疫缺陷和传染病的特殊血浆衍生生物制剂，市值为 46.6 亿美元。</p>
</div><p><strong>Operations:</strong> ADMA Biologics generates revenue primarily through its biomanufacturing segment, which accounts for $481.64 million, while its plasma collection centers contribute $6.77 million.</p>
<div class="lb-trans"><p><strong>运营：</strong> ADMA Biologics 主要通过其生物制造部门产生收入，该部门的收入为 4.8164 亿美元，而其血浆采集中心贡献了 677 万美元。</p>
</div><p>ADMA Biologics has demonstrated robust financial performance, with a notable 207.4% surge in earnings over the past year, significantly outpacing the industry's growth. This trend is complemented by an impressive forecast of 23% annual earnings growth and a revenue increase at 19.6% annually, both exceeding market averages. The company's strategic R&amp;D investments have been pivotal, aligning with its revenue to foster innovation and maintain competitive advantage in the biotech sector. Recently, ADMA raised its fiscal projections for 2025 and 2026 while continuing to enhance shareholder value through aggressive share repurchases totaling $23.01 million this year. These actions reflect a proactive approach in scaling operations and potentially securing long-term growth amidst dynamic market conditions.</p>
<div class="lb-trans"><p>ADMA Biologics 展现出强劲的财务表现，过去一年盈利增长显著，达到 207.4%，远超行业增长。这一趋势得到了 23% 的年盈利增长预测和 19.6% 的年收入增长的支持，均超过市场平均水平。公司的战略研发投资至关重要，与其收入相结合，促进了创新并保持了在生物科技领域的竞争优势。最近，ADMA 提高了 2025 年和 2026 年的财务预测，同时通过今年 2301 万美元的积极股票回购继续提升股东价值。这些举措反映了在动态市场条件下扩大运营和潜在确保长期增长的积极态度。</p>
</div><ul>
<li>Unlock comprehensive insights into our analysis of ADMA Biologics stock in this health report.</li>
<li>Evaluate ADMA Biologics' historical performance by accessing our past performance report.</li>
</ul>
<div class="lb-trans"><ul>
<li>解锁我们对 ADMA Biologics 股票分析的全面见解，请查看本健康报告。</li>
<li>通过访问我们的历史表现报告，评估 ADMA Biologics 的历史表现。</li>
</ul>
</div><p><img src="https://imageproxy.pbkrs.com/https://images.simplywall.st/company/f89ca4c1-8d8c-472e-b71e-3bd45378af08/chart/revenue-and-expenses-breakdown" alt="" original-src="https://images.simplywall.st/company/f89ca4c1-8d8c-472e-b71e-3bd45378af08/chart/revenue-and-expenses-breakdown"/></p>
<p>ADMA Revenue and Expenses Breakdown as at Dec 2025</p>
<div class="lb-trans"><p>截至 2025 年 12 月的 ADMA 收入和支出明细</p>
</div><h2>CarGurus (CARG)</h2>
<div class="lb-trans"><h2>CarGurus (CARG)</h2>
</div><p><strong>Simply Wall St Growth Rating:</strong> ★★★★☆☆</p>
<div class="lb-trans"><p><strong>Simply Wall St 增长评级：</strong> ★★★★☆☆</p>
</div><p><strong>Overview:</strong> CarGurus, Inc. operates an online automotive platform facilitating the buying and selling of vehicles both in the United States and internationally, with a market cap of approximately $3.69 billion.</p>
<div class="lb-trans"><p><strong>概述：</strong> CarGurus, Inc. 运营一个在线汽车平台，促进美国及国际范围内的车辆买卖，市值约为 36.9 亿美元。</p>
</div><p><strong>Operations:</strong> The company primarily generates revenue from its U.S. Marketplace segment, which accounts for $801.72 million, complemented by its Digital Wholesale segment at $50.35 million.</p>
<div class="lb-trans"><p><strong>运营：</strong> 该公司主要通过其美国市场部门产生收入，该部门的收入为 8.0172 亿美元，数字批发部门的收入为 5035 万美元。</p>
</div><p>CarGurus has demonstrated a significant turnaround, becoming profitable this year with a net income of $106.11 million compared to a net loss last year. This shift is underscored by robust earnings growth at 22.4% annually, outpacing the US market average of 16.2%. The company's strategic focus on R&amp;D and product innovation is evident in its recent launch of PriceVantage, a pricing solution that leverages real-time data to optimize dealership pricing strategies effectively. This tool has already enabled engaged dealers to significantly outperform competitors in turn times. Additionally, CarGurus' proactive share repurchases, totaling $295.23 million this year, reflect its commitment to shareholder value and confidence in sustained growth despite its revenue forecast growing at a slower pace (6.3% annually) compared to the market (10.7%).</p>
<div class="lb-trans"><p>CarGurus 展现出显著的扭转局面，今年实现盈利，净收入为 1.0611 亿美元，而去年则出现净亏损。这一转变得益于 22.4% 的年盈利增长，超过美国市场平均水平的 16.2%。公司在研发和产品创新方面的战略重点体现在其最近推出的 PriceVantage，这是一种利用实时数据优化经销商定价策略的定价解决方案。该工具已经使参与的经销商在周转时间上显著超越竞争对手。此外，CarGurus 今年的股票回购总额达到 2.9523 亿美元，反映了其对股东价值的承诺和对持续增长的信心，尽管其收入预测的增长速度（每年 6.3%）低于市场（10.7%）。</p>
</div><ul>
<li>Take a closer look at CarGurus' potential here in our health report.</li>
<li>Examine CarGurus' past performance report to understand how it has performed in the past.</li>
</ul>
<div class="lb-trans"><ul>
<li>在我们的健康报告中更深入地了解 CarGurus 的潜力。</li>
<li>查看 CarGurus 的历史表现报告，以了解其过去的表现。</li>
</ul>
</div><p><img src="https://imageproxy.pbkrs.com/https://images.simplywall.st/company/de4c7c87-7486-4613-8996-bf1d7d679595/chart/revenue-and-expenses-breakdown" alt="" original-src="https://images.simplywall.st/company/de4c7c87-7486-4613-8996-bf1d7d679595/chart/revenue-and-expenses-breakdown"/></p>
<p>CARG Revenue and Expenses Breakdown as at Dec 2025</p>
<div class="lb-trans"><p>截至 2025 年 12 月的 CARG 收入和支出明细</p>
</div><h2>Roku (ROKU)</h2>
<div class="lb-trans"><h2>Roku (ROKU)</h2>
</div><p><strong>Simply Wall St Growth Rating:</strong> ★★★★☆☆</p>
<div class="lb-trans"><p><strong>Simply Wall St 增长评级：</strong> ★★★★☆☆</p>
</div><p><strong>Overview:</strong> Roku, Inc. operates a TV streaming platform both in the United States and internationally, with a market capitalization of approximately $16.08 billion.</p>
<div class="lb-trans"><p><strong>概述：</strong> Roku, Inc. 运营一个电视流媒体平台，覆盖美国及国际市场，市值约为 160.8 亿美元。</p>
</div><p><strong>Operations:</strong> Roku generates revenue primarily through its Platform segment, which accounts for $3.96 billion, significantly exceeding the $587.13 million from its Devices segment.</p>
<div class="lb-trans"><p><strong>运营：</strong> Roku 主要通过其平台部门产生收入，该部门的收入为 39.6 亿美元，远超其设备部门的 5.8713 亿美元。</p>
</div><p>Roku's trajectory in the competitive streaming sector is marked by strategic innovations and partnerships aimed at enhancing its market position and addressing industry challenges. Recently, Roku reported a significant turnaround with third-quarter sales reaching $1.21 billion, up from $1.06 billion the previous year, reflecting an 11% annual revenue growth which outpaces the US market average of 10.7%. This growth is complemented by a shift to profitability, with net income hitting $24.81 million compared to a loss in the same period last year. Additionally, Roku's collaboration with DoubleVerify has been pivotal in combating ad fraud within connected TV advertising, showcasing its commitment to secure and enhance advertising quality on its platform. These efforts are underscored by recent earnings results and strategic alliances that not only bolster Roku’s revenue streams but also fortify its standing in the digital advertising realm, setting a robust foundation for future growth.</p>
<div class="lb-trans"><p>Roku 在竞争激烈的流媒体行业中的发展轨迹以战略创新和合作伙伴关系为标志，旨在增强其市场地位并应对行业挑战。最近，Roku 报告了显著的扭转，第三季度销售额达到 12.1 亿美元，较去年同期的 10.6 亿美元增长，反映出 11% 的年收入增长，超过美国市场平均水平的 10.7%。这一增长伴随着盈利能力的转变，净收入达到 2481 万美元，而去年同期则出现亏损。此外，Roku 与 DoubleVerify 的合作在打击连接电视广告中的广告欺诈方面发挥了关键作用，展示了其在平台上确保和提升广告质量的承诺。这些努力通过最近的财报结果和战略联盟得到了强调，不仅增强了 Roku 的收入来源，还巩固了其在数字广告领域的地位，为未来的增长奠定了坚实的基础。</p>
</div><ul>
<li>Dive into the specifics of Roku here with our thorough health report.</li>
<li>Assess Roku's past performance with our detailed historical performance reports.</li>
</ul>
<div class="lb-trans"><ul>
<li>在这里深入了解 Roku 的具体情况，查看我们的详细健康报告。</li>
<li>通过我们的历史业绩报告评估 Roku 的过去表现。</li>
</ul>
</div><p><img src="https://imageproxy.pbkrs.com/https://images.simplywall.st/company/744f6447-c3ab-4606-b8bc-5bdfa4635280/chart/revenue-and-expenses-breakdown" alt="" original-src="https://images.simplywall.st/company/744f6447-c3ab-4606-b8bc-5bdfa4635280/chart/revenue-and-expenses-breakdown"/></p>
<p>ROKU Revenue and Expenses Breakdown as at Dec 2025</p>
<div class="lb-trans"><p>截至 2025 年 12 月的 ROKU 收入和支出细分</p>
</div><h2>Summing It All Up</h2>
<div class="lb-trans"><h2>总结</h2>
</div><ul>
<li>Click here to access our complete index of 75 US High Growth Tech and AI Stocks.</li>
<li>Invested in any of these stocks? Simplify your portfolio management with Simply Wall St and stay ahead with our alerts for any critical updates on your stocks.</li>
<li>Simply Wall St is your key to unlocking global market trends, a free user-friendly app for forward-thinking investors.</li>
</ul>
<div class="lb-trans"><ul>
<li>点击这里访问我们完整的 75 只美国高增长科技和人工智能股票索引。</li>
<li>投资了这些股票吗？通过 Simply Wall St 简化您的投资组合管理，并及时获取股票的关键更新提醒。</li>
<li>Simply Wall St 是您解锁全球市场趋势的关键，是一款面向前瞻性投资者的免费用户友好应用。</li>
</ul>
</div><h2>Ready To Venture Into Other Investment Styles?</h2>
<div class="lb-trans"><h2>准备探索其他投资风格吗？</h2>
</div><ul>
<li>Explore high-performing small cap companies that haven't yet garnered significant analyst attention.</li>
<li>Fuel your portfolio with companies showing strong growth potential, backed by optimistic outlooks both from analysts and management.</li>
<li>Find companies with promising cash flow potential yet trading below their fair value.</li>
</ul>
<div class="lb-trans"><ul>
<li>探索尚未获得显著分析师关注的高表现小型公司。</li>
<li>用显示强劲增长潜力的公司充实您的投资组合，得到分析师和管理层的乐观展望支持。</li>
<li>寻找现金流潜力良好但交易价格低于其公允价值的公司。</li>
</ul>
</div><p><em>This article by Simply Wall St is general in nature. <strong>We provide commentary based on historical data and analyst forecasts only using an unbiased methodology and our articles are not intended to be financial advice.</strong> It does not constitute a recommendation to buy or sell any stock, and does not take account of your objectives, or your financial situation. We aim to bring you long-term focused analysis driven by fundamental data. Note that our analysis may not factor in the latest price-sensitive company announcements or qualitative material. Simply Wall St has no position in any stocks mentioned.</em></p>
<div class="lb-trans"><p><em>本文由 Simply Wall St 撰写，内容具有一般性。<strong>我们基于历史数据和分析师预测提供评论，仅使用无偏见的方法，我们的文章不构成财务建议。</strong> 它不构成买入或卖出任何股票的推荐，也未考虑您的目标或财务状况。我们的目标是为您提供以基本数据驱动的长期分析。请注意，我们的分析可能未考虑最新的价格敏感公司公告或定性材料。Simply Wall St 在提到的任何股票中没有持仓。</em></p>
</div><p>Mobile Infrastructure for Defense and Disaster</p>
<div class="lb-trans"><p>用于国防和灾难的移动基础设施</p>
</div><p>The next wave in robotics isn't humanoid. Its fully autonomous towers delivering 5G, ISR, and radar in under 30 minutes, anywhere.</p>
<div class="lb-trans"><p>下一波机器人技术不是人形的。它是完全自主的塔，在 30 分钟内提供 5G、ISR 和雷达，随处可达。</p>
</div><p>Get the investor briefing before the next round of contracts</p>
<div class="lb-trans"><p>在下一轮合同之前获取投资者简报</p>
</div><p>Sponsored On Behalf of CiTech</p>
<div class="lb-trans"><p>代表 CiTech 赞助</p>
</div>

High Growth Tech Stocks To Watch In US December 2025

- 美国科技股因 GDP 增长和市场反弹继续走强。  
- ADMA Biologics 和 CarGurus 业绩突出，显示创新潜力。  
- Roku 聚焦广告质量提升，实现盈利和收入增长。

2025 年 12 月美国值得关注的高增长科技股票